- Home
- DFH vs CERT Comparison
DFH vs CERT Comparison
Compare DFH & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFH
- CERT
- Stock Information
- Founded
- DFH 2008
- CERT 2008
- Country
- DFH United States
- CERT United States
- Employees
- DFH N/A
- CERT N/A
- Industry
- DFH Homebuilding
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- DFH Consumer Discretionary
- CERT Technology
- Exchange
- DFH Nasdaq
- CERT Nasdaq
- Market Cap
- DFH 2.2B
- CERT 1.9B
- IPO Year
- DFH 2021
- CERT 2020
- Fundamental
- Price
- DFH $23.30
- CERT $12.68
- Analyst Decision
- DFH Hold
- CERT Buy
- Analyst Count
- DFH 1
- CERT 8
- Target Price
- DFH $26.00
- CERT $15.57
- AVG Volume (30 Days)
- DFH 292.4K
- CERT 1.8M
- Earning Date
- DFH 10-31-2025
- CERT 11-06-2025
- Dividend Yield
- DFH N/A
- CERT N/A
- EPS Growth
- DFH 0.34
- CERT N/A
- EPS
- DFH 3.08
- CERT 0.05
- Revenue
- DFH $4,708,435,000.00
- CERT $405,755,000.00
- Revenue This Year
- DFH $6.07
- CERT $11.70
- Revenue Next Year
- DFH $1.25
- CERT $8.03
- P/E Ratio
- DFH $7.54
- CERT $255.18
- Revenue Growth
- DFH 20.19
- CERT 11.61
- 52 Week Low
- DFH $19.65
- CERT $8.64
- 52 Week High
- DFH $34.43
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- DFH 39.28
- CERT 55.27
- Support Level
- DFH $22.80
- CERT $12.03
- Resistance Level
- DFH $23.67
- CERT $12.83
- Average True Range (ATR)
- DFH 0.90
- CERT 0.57
- MACD
- DFH -0.00
- CERT -0.05
- Stochastic Oscillator
- DFH 37.05
- CERT 53.46
About DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.